Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma.

Ledda-Columbano GM, Perra A, Concas D, Cossu C, Molotzu F, Sartori C, Shinozuka H, Columbano A.

Toxicol Pathol. 2003 Jan-Feb;31(1):113-20.

PMID:
12597455
2.

Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas.

Ledda-Columbano GM, Perra A, Loi R, Shinozuka H, Columbano A.

Cancer Res. 2000 Feb 1;60(3):603-9.

3.

Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions.

Ledda-Columbano GM, Perra A, Piga R, Pibiri M, Loi R, Shinozuka H, Columbano A.

Carcinogenesis. 1999 Dec;20(12):2299-304.

PMID:
10590223
5.
7.
8.

The development of hepatocellular carcinoma in initiated rat liver after a brief exposure to orotic acid coupled with partial hepatectomy.

Laconi E, Vasudevan S, Rao PM, Rajalakshmi S, Pani P, Sarma DS.

Carcinogenesis. 1993 Dec;14(12):2527-30.

PMID:
8269623
10.
11.
12.

Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.

Glauert HP, Beer D, Rao MS, Schwarz M, Xu YD, Goldsworthy TL, Coloma J, Pitot HC.

Cancer Res. 1986 Sep;46(9):4601-6.

13.
14.

Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid.

Pascale RM, Simile MM, De Miglio MR, Nufris A, Daino L, Seddaiu MA, Rao PM, Rajalakshmi S, Sarma DS, Feo F.

Carcinogenesis. 1995 Feb;16(2):427-30.

PMID:
7859377
15.

Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver.

Williams GM, Iatropoulos MJ, Wang CX, Jeffrey AM, Thompson S, Pittman B, Palasch M, Gebhardt R.

Toxicol Sci. 1998 Oct;45(2):152-61.

PMID:
9848122
16.

Dose response study of N-nitrosodiethanolamine initiation of rat hepatocarcinogenesis.

Ogawa K, Hasegawa R, Wada S, Yamaguchi S, Ito N.

Teratog Carcinog Mutagen. 1991;11(5):245-50.

PMID:
1687902
17.

Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.

De Miglio MR, Simile MM, Muroni MR, Pusceddu S, Calvisi D, Carru A, Seddaiu MA, Daino L, Deiana L, Pascale RM, Feo F.

Mol Carcinog. 1999 May;25(1):21-9.

PMID:
10331741
19.
20.

Changes in drug-metabolizing enzymes of rats in ciprofibrate-induced hepatic nodules.

Roomi MW, Farber E, Parke DV.

Xenobiotica. 1997 Sep;27(9):951-60.

PMID:
9381735

Supplemental Content

Support Center